Hinge Health (NYSE:HNGE - Free Report) had its price objective hoisted by KeyCorp from $45.00 to $60.00 in a research note published on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.
HNGE has been the subject of several other reports. Canaccord Genuity Group started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $52.00 target price for the company. Raymond James Financial started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued an "outperform" rating and a $45.00 target price for the company. Truist Financial started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $48.00 target price for the company. Morgan Stanley started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued an "overweight" rating and a $46.00 target price for the company. Finally, Needham & Company LLC started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $47.00 target price for the company. One research analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $49.36.
View Our Latest Stock Analysis on HNGE
Hinge Health Stock Down 1.6%
Shares of HNGE stock traded down $0.77 during trading hours on Monday, hitting $46.18. The company's stock had a trading volume of 258,737 shares, compared to its average volume of 1,000,045. Hinge Health has a 12-month low of $33.42 and a 12-month high of $52.16.
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
See Also
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
